Minocycline-induced lupus - A systematic review

被引:65
|
作者
Schlienger, RG [1 ]
Bircher, AJ
Meier, CR
机构
[1] Univ Basel Hosp, Div Clin Pharmacol, Basel Pharmacoepidemiol Unit, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Div Dermatol, CH-4031 Basel, Switzerland
[3] Univ Basel, Dept Pharm, Inst Pharmacotherapy, CH-4003 Basel, Switzerland
[4] Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA USA
关键词
minocycline; auto-immune diseases; drug-induced lupus;
D O I
10.1159/000018387
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Minocycline has increasingly been associated with different adverse auto-immune reactions including drug-induced lupus, Objective: To identify the scope of minocycline-induced lupus and to characterise its typical features. Methods: Comprehensive Medline and Embase search of the English and non-English literature for case reports of minocyctine-induced lupus. Results: We included 57 cases of minocycline-induced lupus (mean age +/- SD at onset: 21.6 +/- 8.6 years, median time of exposure: 19 months, range 3 days to 6 years). All patients showed the clinical features of polyarthralgia/ polyarthritis often accompanied by liver abnormalities. Twelve patients had evidence of dermatological manifestations (i.e rash, livedo reticularis, oral ulceration, subcutaneous nodules, alopecia). The ANA test was positive in all patients. Conclusion: Long-term exposure to minocycline may be associated with drug-induced lupus. Baseline and periodic liver function and ANA tests accompanied by appropriate clinical monitoring are suggested for patients receiving long-term minocycline therapy. Copyright (C) 2000 S. Karger AG,Basel.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 50 条
  • [31] Minocycline-induced black bone disease of the skull
    Ohyama, Koji
    Nakae, Shunsuke
    Uehara, Yuki
    INFECTION, 2024, 52 (06) : 2551 - 2552
  • [33] Minocycline-induced transient depersonalization: A case report
    Shamout, Yassein
    Sigal, Alissa
    Litvinov, Ivan, V
    SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
  • [34] Minocycline-induced activation of tetracycline-responsive promoter
    Chtarto, A
    Tenenbaum, L
    Velu, T
    Brotchi, J
    Levivier, M
    Blum, D
    NEUROSCIENCE LETTERS, 2003, 352 (03) : 155 - 158
  • [35] Black veins: a case of minocycline-induced pigmentation post-sclerotherapy and a review of literature
    Star, Phoebe
    Choy, Carolyn
    Parsi, Kurosh
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (01) : 83 - 92
  • [36] Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome
    Dunphy, J
    Oliver, M
    Rands, AL
    Lovell, CR
    McHugh, NJ
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (03) : 461 - 467
  • [37] Follicular carcinoma associated with minocycline-induced black thyroid
    Jennings, TA
    Sheehan, CE
    Chodos, RB
    Figge, J
    ENDOCRINE PATHOLOGY, 1996, 7 (04) : 345 - 348
  • [38] Minocycline-induced Polyarteritis Nodosa-Like Vasculitis
    Agur, Timna
    Levy, Yair
    Plotkin, Eleonora
    Benchetrit, Sydney
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (05): : 322 - 323
  • [39] Minocycline-induced drug hypersensitivity syndrome with hepatic disease
    Trivin, C
    Brion, JP
    Bourrain, JL
    Mallaret, M
    Allenet, B
    Calop, J
    THERAPIE, 2005, 60 (06): : 590 - 593
  • [40] Minocycline-induced DRESS: Evidence for accumulation of the culprit drug
    Maubec, Eve
    Wolkenstein, Pierre
    Loriot, Marie-Anne
    Wechsler, Janine
    Mulot, Claire
    Beaune, Philippe
    Revuz, Jean
    Roujeau, Jean-Claude
    DERMATOLOGY, 2008, 216 (03) : 200 - 204